Form 8-K - Current report:
SEC Accession No. 0001104659-25-045127
Filing Date
2025-05-06
Accepted
2025-05-06 17:20:30
Documents
25
Period of Report
2025-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513673d1_8k.htm   iXBRL 8-K 243958
2 EXHIBIT 2.2 tm2513673d1_ex2-2.htm EX-2.2 11717
3 EXHIBIT 2.3 tm2513673d1_ex2-3.htm EX-2.3 23582
4 EXHIBIT 3.1 tm2513673d1_ex3-1.htm EX-3.1 49947
5 EXHIBIT 4.4 tm2513673d1_ex4-4.htm EX-4.4 15087
6 EXHIBIT 10.1 tm2513673d1_ex10-1.htm EX-10.1 128657
7 EXHIBIT 14.1 tm2513673d1_ex14-1.htm EX-14.1 39967
8 EXHIBIT 16.1 tm2513673d1_ex16-1.htm EX-16.1 2938
9 EXHIBIT 21.1 tm2513673d1_ex21-1.htm EX-21.1 1952
10 EXHIBIT 99.1 tm2513673d1_ex99-1.htm EX-99.1 90109
11 EXHIBIT 99.2 tm2513673d1_ex99-2.htm EX-99.2 231800
12 EXHIBIT 99.3 tm2513673d1_ex99-3.htm EX-99.3 323824
  Complete submission text file 0001104659-25-045127.txt   1579355

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA limn-20250430.xsd EX-101.SCH 3359
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE limn-20250430_def.xml EX-101.DEF 28661
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE limn-20250430_lab.xml EX-101.LAB 38284
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE limn-20250430_pre.xml EX-101.PRE 26870
27 EXTRACTED XBRL INSTANCE DOCUMENT tm2513673d1_8k_htm.xml XML 7136
Mailing Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623
Business Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623 213-273-5453
Liminatus Pharma, Inc. (Filer) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42626 | Film No.: 25918369
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)